Bouthaina Dabaja
UT MD Anderson · M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bouthaina Dabaja as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:20 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07856758 · 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell TherapyM.D. Anderson Cancer Center · not yet recruiting · Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT05357794 · Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis FungoidesM.D. Anderson Cancer Center · recruiting · Mycosis Fungoides · principal investigator
- Ph2NCT02106988 · Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell LymphomaM.D. Anderson Cancer Center · active not recruiting · Lymphoma · principal investigator
- Ph1/Ph2NCT01321008 · Stage I/II Nasal NK Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
- Ph2NCT01073267 · Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis FungoidesM.D. Anderson Cancer Center · completed · Lymphoma · study chair
- N/ANCT00925405 · Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyM.D. Anderson Cancer Center · terminated · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:20 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.J Clin Oncol · 2010112 citationsRCR 3.4
- Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.Leuk Lymphoma · 200185 citationsRCR 1.6
- Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.Ann Oncol · 201575 citationsRCR 3.1
- Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.Blood · 201769 citationsRCR 2.0
- Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.Blood · 201259 citationsRCR 1.4
- Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience.Leuk Lymphoma · 201056 citationsRCR 1.5
- Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.J Hematol Oncol · 202356 citationsRCR 4.6
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.Biol Blood Marrow Transplant · 201543 citationsRCR 1.2
- Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.Blood Adv · 201834 citationsRCR 1.4
- Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.Am J Hematol · 201732 citationsRCR 1.2